Delivery Order SPE2DB25D3202-SPE2DB25FTBMU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of epinephrine 0.15 mg auto-injectors (two-pack units) under a firm fixed-price contract with a ceiling value of $1,477.10. This non-set-aside competitive award is classified as a delivery order and carries an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) valued at $1,733.94. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's capability to compete openly for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,086.91. This is a firm fixed-price delivery order with a completion date of September 5, 2025, and represents a competitively awarded contract with no set-aside designation. The award was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,533.52 and a completion date of September 18, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal supply arrangement. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Epinephrine 0.15 mg auto-injectors in a two-pack configuration. This contract, valued at $11,352.44, represents a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units) with a ceiling value of $1,547.00 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within DLA's pharmaceutical procurement framework. The contract utilizes no set-aside designation, reflecting AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $1,595.49. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $1,308.27. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,560.55 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for ultimate completion on September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of epinephrine 0.15 mg auto-injector two-packs under a firm fixed-price contract. This non-set-aside award carries a ceiling value of $15,320.45 and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBMUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,408.94. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and no set-aside designation was applied to the award. The contractor will perform under this order from its Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical hub for pharmaceutical distribution operations. This delivery order is a child action under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements competitively, including specialty medications, vaccines, and medical devices across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/29/25 |